Share Email Print

Proceedings Paper

Measured skin damage thresholds for 1314-nm laser exposures
Author(s): Cecilia I. Montes de Oca; Clarence P. Cain; Kurt J. Schuster; Kevin Stockton; James J. Thomas; Thomas A. Eggleston; William P. Roach
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The use of lasers in the infrared region between 1200-1400 nm has steadily increased in various industrial and commercial applications. However, there are few studies documenting damage thresholds for the skin in this region, and current laser safety standards are based on limited data. This study has determined preliminary skin damage thresholds for the Effective Dose for 50% probability (ED50) of a Minimum Visible Lesion (MVL) with laser exposure at 1314nm and 0.35 ms pulse width. An in-vivo pigmented animal model, Yucatan mini-pig (Sus scrofa domestica), was used in this study. The type and extent of tissue damage in the porcine skin was determined through histopathologic examination, and the findings are discussed. Finally, the results of this study were compared to other literature as well as to the existing ANSI Z136.1 (2000) standard for safe use of lasers.

Paper Details

Date Published: 20 June 2003
PDF: 7 pages
Proc. SPIE 4953, Laser and Noncoherent Light Ocular Effects: Epidemiology, Prevention, and Treatment III, (20 June 2003); doi: 10.1117/12.477902
Show Author Affiliations
Cecilia I. Montes de Oca, Air Force Research Lab. (United States)
Clarence P. Cain, Northrop Grumman IT (United States)
Kurt J. Schuster, Northrop Grumman IT (United States)
Kevin Stockton, Northrop Grumman IT (United States)
James J. Thomas, Air Force Research Lab. (United States)
Thomas A. Eggleston, U.S. Army Veterinary Sciences (United States)
William P. Roach, Air Force Research Lab. (United States)

Published in SPIE Proceedings Vol. 4953:
Laser and Noncoherent Light Ocular Effects: Epidemiology, Prevention, and Treatment III
Bruce E. Stuck; Michael Belkin, Editor(s)

© SPIE. Terms of Use
Back to Top